Literature DB >> 7701048

Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis.

M Herrera-Marschitz1, J Luthman, S Ferré.   

Abstract

6-hydroxydopamine (6-OHDA, 100 micrograms in 5 microliters) was injected into the right ventricle of 3-day-old Sprague-Dawley rats in order to produce a unilateral dopamine (DA) lesion. At adult stage, the rats were implanted with microdialysis probes into the left and right striata. On the injected side, basal extracellular levels of DA were reduced by > 65%, as compared to the contralateral side or to the levels found in vehicle-injected rats. Extracellular 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were reduced by > 95%, while acetylcholine (ACh) was decreased by > 50%. d-Amphetamine (2 mg/kg SC) produced a 10-fold increase in extracellular DA levels in the striatum contralateral to the 6-OHDA-injected side, while on the ipsilateral side. DA levels were not affected by d-amphetamine. d-Amphetamine produced an increase (> 2 fold) in extracellular ACh levels, on both ipsilateral and contralateral sides. Choline and adenosine levels were unaffected by any of the experimental conditions. Thus, neonatal unilateral ICV administration of 6-OHDA produced an ipsilateral decrease in striatal extracellular DA, DOPAC and HVA levels, compared to the contralateral side. A reduction of extracellular ACh levels was also observed on the 6-OHDA-injected side. The DA releasing effect of d-amphetamine was abolished on the 6-OHDA-injected side, but not that on ACh levels, indicating that striatal DA and ACh d-amphetamine-induced release are produced by independent mechanisms in the neonatally unilateral 6-OHDA-treated animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701048     DOI: 10.1007/bf02247477

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.

Authors:  J Luthman; E Brodin; E Sundström; B Wiehager
Journal:  Int J Dev Neurosci       Date:  1990       Impact factor: 2.457

2.  Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia.

Authors:  D G Van Wylen; T S Park; R Rubio; R M Berne
Journal:  J Cereb Blood Flow Metab       Date:  1986-10       Impact factor: 6.200

3.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

4.  Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study.

Authors:  H T Chang
Journal:  Brain Res Bull       Date:  1988-08       Impact factor: 4.077

5.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.

Authors:  J Luthman; M Herrera-Marschitz; E Lindqvist
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

6.  In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum.

Authors:  J Luthman; M N Friedemann; B J Hoffer; G A Gerhardt
Journal:  Exp Neurol       Date:  1993-08       Impact factor: 5.330

7.  Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions.

Authors:  M Herrera-Marschitz; J J Meana; W T O'Connor; M Goiny; M S Reid; U Ungerstedt
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

8.  Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: effects of treatment with monosialoganglioside GM1.

Authors:  D Maysinger; M Herrera-Marschitz; A Carlsson; L Garofalo; A C Cuello; U Ungerstedt
Journal:  Brain Res       Date:  1988-10-04       Impact factor: 3.252

9.  Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.

Authors:  M Reid; M Herrera-Marschitz; T Hökfelt; L Terenius; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

10.  Similar post-lesion receptor readjustments following the unilateral 6-hydroxydopamine lesion of the dopaminergic mesotelencephalic system in neonatal and adult rats.

Authors:  D N Abrous; J M Rivet; M Le Moal; J P Herman
Journal:  Brain Res       Date:  1990-09-03       Impact factor: 3.252

View more
  11 in total

1.  Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats.

Authors:  Nicola Simola; Diego Bustamante; Annalisa Pinna; Silvia Pontis; Paola Morales; Micaela Morelli; Mario Herrera-Marschitz
Journal:  Exp Brain Res       Date:  2007-11-08       Impact factor: 1.972

2.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.

Authors:  J Luthman; M Herrera-Marschitz; E Lindqvist
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 3.  Probing striatal microcircuitry to understand the functional role of cholinergic interneurons.

Authors:  Allison E Girasole; Alexandra B Nelson
Journal:  Mov Disord       Date:  2015-07-30       Impact factor: 10.338

4.  Effects of chronic caffeine exposure on adenosinergic modulation of the discriminative-stimulus effects of nicotine, methamphetamine, and cocaine in rats.

Authors:  Zuzana Justinova; Sergi Ferré; Chanel Barnes; Carrie E Wertheim; Lara A Pappas; Steven R Goldberg; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2008-08-08       Impact factor: 4.530

5.  Presynaptic involvement in the nicotine prevention of the dopamine loss provoked by 6-OHDA administration in the substantia nigra.

Authors:  J Andrés Abin-Carriquiry; Ronald McGregor-Armas; Gustavo Costa; Jessika Urbanavicius; Federico Dajas
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

6.  Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.

Authors:  Przemyslaw Nowak; Aleksandra Bortel; Joanna Dabrowska; Joanna Oswiecimska; Marzena Drosik; Adam Kwiecinski; Józef Opara; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2007-02       Impact factor: 3.911

7.  Dopamine-Induced Changes in Gαolf Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian Mice.

Authors:  Ryoma Morigaki; Shinya Okita; Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2017-02-10       Impact factor: 5.505

8.  Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease.

Authors:  Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2017-11-21       Impact factor: 5.505

9.  Intracerebral microdialysis of adenosine and adenosine monophosphate - a systematic review and meta-regression analysis of baseline concentrations.

Authors:  Stevie van der Mierden; Sergey A Savelyev; Joanna IntHout; Rob B M de Vries; Cathalijn H C Leenaars
Journal:  J Neurochem       Date:  2018-09-27       Impact factor: 5.372

10.  Striatal Acetylcholine-Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET-Informed Correlational Tractography.

Authors:  Carlos A Sanchez-Catasus; Nicolaas I Bohnen; Nicholas D'Cruz; Martijn L T M Müller
Journal:  J Nucl Med       Date:  2021-07-16       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.